Literature DB >> 8664986

Stimulation of thyroid cell proliferation by epidermal growth factor is different from cell growth induced by thyrotropin or insulin-like growth factor I.

G Bechtner1, D Schopohl, M Rafferzeder, R Gärtner, U Welsch.   

Abstract

Isolated intact porcine thyroid follicles free of contaminating single cells were embedded in "Matrigel", which is a gel-forming basement membrane preparation containing mainly collagen type IV, laminin, heparan sulfate proteoglycans and entactin. Follicles were treated with different growth factors: thyrotropin (TSH), insulin-like growth factor I (IGF-I), epidermal growth factor (EGF) or transforming growth factor beta. Cell proliferation was quantified by counting cell numbers. Morphological studies were done by photodocumentation and analysis of histology by light and electron microscopy. The thyrocytes had the physiological polarity with follicular cell arrangement, microvilli at the apical membrane, desmosomes and tight junctions. The lumen contained colloid. Iodide organification (10.2 +/- 2.1 vs 26.1 +/- 5.8 pmol/10(6) cells; TSH 0.1 mU/ml) and release of thyroid hormones (thyroxine, 1754 +/- 207 vs 2890 +/- 460 pg/10(6) cells; triiodothyronine, 164 +/- 22 vs 412 +/- 106 pg/10(6) cells; TSH, 1mU/ml) were significantly stimulated by TSH. There was no basal growth rate in serum-free medium but proliferation was slightly stimulated with TSH (1 mU/ml; 149 +/- 19%) and in the same order of magnitude with IGF-I (10 ng/ml; 159 +/- 23%) but without follicle neoformation. In contrast, BGF (1.0-5.0 ng/ml) induced thyrocyte proliferation dose dependently three- to sixfold. With BGF up to 2 ng/ml, buds of new follicles formed surrounding pre-existing follicles. With BGF higher than 3 ng/ml, typical papillary structures developed. Transforming growth factor beta inhibited this dedifferentiated growth. A migration of single cells into the gel was never observed. Thus, three-dimensional culture of isolated thyroid follicles in "Matrigel" provides a tool for investigating the regulation of follicular growth and neoformation close to the in vivo situation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8664986     DOI: 10.1530/eje.0.1340639

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

1.  Acromegaly and thyroid.

Authors:  Klaus von Werder
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

2.  Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.

Authors:  Manoj Garg; Deepika Kanojia; Ryoko Okamoto; Saket Jain; Vikas Madan; Wenwen Chien; Abhishek Sampath; Ling-Wen Ding; Meng Xuan; Jonathan W Said; Ngan B Doan; Li-Zhen Liu; Henry Yang; Sigal Gery; Glenn D Braunstein; H Phillip Koeffler
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

3.  Directed differentiation of mouse embryonic stem cells into thyroid follicular cells.

Authors:  Maria C Arufe; Min Lu; Atsushi Kubo; Gordon Keller; Terry F Davies; Reigh-Yi Lin
Journal:  Endocrinology       Date:  2006-02-23       Impact factor: 4.736

4.  The role of insulin-like growth factor 1 in the development of benign and malignant thyroid nodules.

Authors:  Engin Baştürk; Metin Kement; Dilek Yavuzer; Selahattin Vural; Cem Gezen; Hülya Ilıksu Gözü; Ayşe Karadayı; Mustafa Oncel
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

5.  Fabrication of Functional Cell Sheets with Human Thyrocytes from Non-Tumorous Thyroid Tissue.

Authors:  Yu Huang; Kosho Yamanouchi; Yusuke Sakai; Sayaka Kuba; Chika Sakimura; Michi Morita; Kengo Kanetaka; Mitsuhisa Takatsuki; Susumu Eguchi
Journal:  Tissue Eng Regen Med       Date:  2019-07-05       Impact factor: 4.169

6.  EGF and TGF-β1 Effects on Thyroid Function.

Authors:  Gabriella Mincione; Maria Carmela Di Marcantonio; Chiara Tarantelli; Sonia D'Inzeo; Arianna Nicolussi; Francesco Nardi; Caterina Francesca Donini; Anna Coppa
Journal:  J Thyroid Res       Date:  2011-06-13

7.  Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells.

Authors:  Koichi Ohno; Tomohiro Shibata; Ken-Ichi Ito
Journal:  Cancer Sci       Date:  2022-07-12       Impact factor: 6.518

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.